LORRAINE TAYLOR: Open Payments
NPI 1235723040 · COLRAIN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 11 payments from 6 companies in 2025. Trend: 2023 $801 · 2024 $1,013 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Lundbeck LLC | 2 | $54 |
| Alkermes, Inc. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
Products named: REXULTI, ARISTADA, AUSTEDO XR, CAPLYTA, FANAPT, INGREZZA, UZEDY.
Industry payments across MA — which companies pay providers there.
